- Home
- INV vs LUCD Comparison
INV vs LUCD Comparison
Compare INV & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INV
- LUCD
- Stock Information
- Founded
- INV 2015
- LUCD 2018
- Country
- INV United States
- LUCD United States
- Employees
- INV N/A
- LUCD N/A
- Industry
- INV
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INV
- LUCD Health Care
- Exchange
- INV NYSE
- LUCD Nasdaq
- Market Cap
- INV 173.3M
- LUCD 140.7M
- IPO Year
- INV N/A
- LUCD 2021
- Fundamental
- Price
- INV $4.65
- LUCD $1.19
- Analyst Decision
- INV Strong Buy
- LUCD Strong Buy
- Analyst Count
- INV 2
- LUCD 4
- Target Price
- INV $14.00
- LUCD $3.94
- AVG Volume (30 Days)
- INV 171.5K
- LUCD 1.5M
- Earning Date
- INV 08-15-2025
- LUCD 08-11-2025
- Dividend Yield
- INV N/A
- LUCD N/A
- EPS Growth
- INV N/A
- LUCD N/A
- EPS
- INV N/A
- LUCD N/A
- Revenue
- INV $1,220,000.00
- LUCD $4,173,000.00
- Revenue This Year
- INV $1,045.66
- LUCD $91.46
- Revenue Next Year
- INV $240.46
- LUCD $213.42
- P/E Ratio
- INV N/A
- LUCD N/A
- Revenue Growth
- INV 18.27
- LUCD 39.89
- 52 Week Low
- INV $3.00
- LUCD $0.72
- 52 Week High
- INV $18.75
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- INV N/A
- LUCD 40.88
- Support Level
- INV N/A
- LUCD $1.00
- Resistance Level
- INV N/A
- LUCD $1.21
- Average True Range (ATR)
- INV 0.00
- LUCD 0.07
- MACD
- INV 0.00
- LUCD -0.01
- Stochastic Oscillator
- INV 0.00
- LUCD 37.50
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.